Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients
Clinical trial NCT04396639 · COMPLETED
Trial details
- NCT number
- NCT04396639
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-25
- Primary completion
- 2020-09-24
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.